Melanoma will affect an estimated 73,000 new cases this year and result in 9,000 deaths, yet precise diagnosis remains a serious problem. Without early detection and preventative care, melanoma can quickly spread to become fatal (Stage IV 5-year survival rate is 20-10%) from a once localized skin lesion (Stage IA 5-year survival rate is 97%). There is no biomarker for melanoma in clinical use, and the current diagnostic criteria for skin lesions remains subjective and imprecise. Accurate diagnosis of melanoma relies on a histopathologic gold standard; thus, aggressive excision of melanocytic skin lesions has been the mainstay of treatment. It is estimated that 36 biopsies are performed for every melanoma confirmed by pathology among excised lesions. There is significant morbidity in misdiagnosing melanoma such as progression of the disease for a false negative prediction vs the risks of unnecessary surgery for a false positive prediction. Every year, poor diagnostic precision adds an estimated $673 million in overall cost to manage the disease.
2 of melanoma) 10 . The progression of the disease is best characterized both clinically and histopathologically, and it can rapidly progress from stage 0 (melanoma in situ) to stage 4 (metastatic melanoma) 11 without proper diagnosis and management.
Accurate clinical diagnosis of melanoma can be challenging
The ABCDE method for visually assessing pigmented skin lesions for malignancy 12 outlines
Asymmetry, Border irregularity, Color variegation, Diameter (>6mm), and Evolution as clinical features to follow 13 . However, diagnostic accuracy of melanoma by the unaided eye is disappointing 14, 15 . The melanoma yield on biopsy of suspicious lesions is only 1 in 36 16 . Dermoscopy 17 facilitates visualization of morphological features which are not discernible by examination with the naked eye 18 , and it enables better diagnosis as compared to unaided eye [19] [20] [21] with an improvement in diagnostic sensitivity of 10-30% 22 . However, dermoscopy may actually lower the diagnostic accuracy in the hands of inexperienced dermatologists [23] [24] [25] [26] , since this method requires great deal of experience to differentiate skin lesions 27 . Experts achieve 90% sensitivity and 59% specificity, while this performance significantly worsens with inexperience and drops to 62%-63%for general practitioners 28, 29 . Currently available computer vision (CV) algorithms perform only marginally better in practice with no significant improvement in diagnosis relative to a dermatologist 30 .
Histopathology remains the gold standard for accurate melanoma diagnosis 31 although the rate of discordant readings between pathologists can be high: when 11 expert pathologists reviewed 37 'classic' melanocytic lesions there was total agreement in only 30% of cases; other studies report up to a 50% discordance rate among pathologists [32] [33] [34] [35] [36] . Thus the diagnostic accuracy of melanoma remains problematic independent of the method used for diagnosis.
Deep learning is emerging because of Big Data
Deep learning (DL) emerged from the traditional neural network paradigm of artificial intelligence that was developed in the 1980s to computationally model neuronal activity in the brain. An artificial neuron is modeled to fire around an activation threshold (or bias) and differentially weighted inputs. However, to interpret complex signals and patterns requires sophisticated models of computational neurons that are chained together to propagate signals much like the visual system in brain interprets light signals with successive cognitive interpretation (retina, V1, V2, etc.) in order to classify objects. Today, the most useful neural network models are composed of thousands of multi-layered artificial neurons that are parameterized by exponentially more biases and weights that require massive datasets to estimate. However, once these networks are trained on sufficiently large high quality labeled datasets, they generally outperform other machine learning methods. The computationally intensive process of accurately estimating their parameters by training on massive datasets constitutes the paradigm of DL. Furthermore, the exponential growth in computational power and the recent emergence of GPU computation, together with the abundance of large data sets to train on makes DL application more practical now than ever before.
Deep Learning facilitates the most accurate image classification
Big data, cheap computation, and better algorithms are making breakthroughs in artificial intelligence such as deep learning (DL) more possible now than ever before 37 . Today, DL is being applied to a variety of tasks with extraordinary results [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] , but the most remarkable progress has been made in the field of computer vision (CV). ImageNet holds an annual Large Scale Visual Recognition Challenge (ILSVRC) competition 54, 55 for teams to classify 1.2 million images of objects into 1,000 categories (). In 2010, all teams used traditional CV algorithms with accuracy rates <71.8%. Only Incremental progress was but also the latest networks Google uses for their own large scale image classification tasks 57 . The active community of developers that are supporting these open tools will be a valuable resource to fine-tuning pre-existing models as well as to build the novel DL architecture to accurately diagnose skin lesion pathology as we propose here.
Results
We performed a successful pilot study to show proof of concept of DL skin pathology from publically available images.
Publically available digital images of skin lesions
Google crawls the Internet to catalog every available image online, and we searched Google Images for "melanocytic skin lesion".
The majority of images of melanocytic skin lesion came from DermNet Skin Atlas 64 , the largest independent photo dermatology source dedicated to online medical education. However only low resolution watermarked lesions ( Figure 2) were freely available to download while high resolution images were available at $50 / image. We scraped freely available low quality images from DermNet and labeled them with DermNet assigned diagnoses. In all we identified 275 images labeled by DermNet comprising 170 atypical lesions (42 atypical nevi + 128 malignant melanoma) and 115 benign lesions (25 halo nevi + 80 melanocytic nevi).
Deep Learning features of digital images
We utilized a type of algorithm called transfer learning to train a DL algorithm to classify skin lesions as typical or atypical. Transfer learning is applicable to our limited dataset on standard personal computer hardware because it assumes 4 a DL reference model for feature selection, with subsequent classification of this imageset by traditional machine learning algorithms. We utilized the BVLC AlexNet model from Caffe Model Zoo to reduce the pixels of each digital image to 4,096 features. We used the Python programming language with scikit-learn open libraries to project the 4,096 features learned from the DL algorithm into 2 dimensions with the TSNE method in order to visualize the relationship among 275 images (Figure 3) . We found that even with the low quality watermarked DermNet images, were were able to identify structure in the relatedness of images. Specifically, nevi clustered together as did images with hair, as well as different subsets of melanoma. Finally, to assess the predictive power of the features extracted by DL, we used a support vector machine (SVM) classifier trained on the 275 DermNet images with parameter optimization by cross validation. We found the area under the curve (AUC) of 0.83 after 10-fold cross validation of the SVM (Figure 4) , and an AUC of of 0.80 to 0.90 represents a "good" measure of accuracy by most standards. We expect that 0.83 is the lower bound on the accuracy of our approach as we will increase our predictive power by training more sophisticated models with much more data.
Conclusion
At this time, computers cannot replace an experienced clinician's intuition. However, with proficient training on sufficient high-quality data, CV algorithms will eventually match, if not exceed, clinical diagnostic accuracy of dermatologists. Applying DL to a large well-characterized prospectively collected clinical imagesets may indeed yield new diagnostic tools to more accurately diagnose skin cancer. Precision diagnostics of melanoma may serve as a first step in significantly reducing the mortality rate and improving the overall management of the disease.
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